Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 34, Issue 6, 2007, Pages 1336-1340

  Gonzalez, Benito ^a   Larrañaga, Carmen ^b   León, Oscar ^b   Díaz, Patricia ^b   Miranda, Marta ^c   Barría, Marcelo ^b   Gaggero, Aldo ^b  

^a HOSPITAL LUIS CALVO MACKENNA   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c HOSPITAL SAN JUAN DE DIOS   (Chile)

Author keywords

Juvenile idiopathic arthritis; Parvovirus B19

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS DNA;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; JUVENILE RHEUMATOID ARTHRITIS; MALE; PARVOVIRUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; VIRUS GENOME;

ADOLESCENT; ANTIBODIES, VIRAL; ARTHRITIS, JUVENILE RHEUMATOID; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREVALENCE;

EID: 34250173130     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis - why does it vary so much? J Rheumatol 2002;29:1520-30.
2. Cassidy JT, Levinson JK, Bass JC, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986;29:274-81.
3. Cassidy JT, Petty RE. Textbook of pediatric rheumatology. Philadelphia: W.B. Saunders Company; 2001:214-7.
4. Prieur AM, Petty RE. Definitions and classifications of chronic arthritis in children. Baillieres Clin Paediatric 1993;1:695.
5. Schneider R, Passo MH. Juvenile rheumatoid arthritis. Rheum Dis Clin North Am 2002;28:503-30.
6. Petty RE, Tingle AJ. Arthritis and viral infection. J Pediatr 1988;113:948-9.
7. Pugh MT, Southwood TR, Gaston JS. The role of infection in juvenile chronic arthritis. Br J Rheumatol 1993;32:838-44.
8. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985;1:419-21.
9. Naides SJ. Parvovirus B19 infection. Rheum Dis Clin North Am 1993;19:457-75.
10. Murai C, Munakata Y, Takahashi Y, et al. Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis 1999;58:130-2.
11. Heegaard E, Brown K. Human parvovirus B19. Clin Microbiol Rev 2002;15:485-505.
12. Shade RO, Blundell MC, Cotmore SF, et al. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-36.
13. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350:586-97.
14. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 2004;53:459-75.
15. Musiani M, Zerbini M, Gentilomi G, et al. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995;172:1360-3.
16. Anderson MJ, Lewis E, Kidd IM, et al. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (London) 1984;93:85-93.
17. Nocton JJ, Miller LC, Tucker LB, Schaller JG. Human parvovirus B19-associated arthritis in children. J Pediat 1993;122:186-90.
18. Takahashi Y, Murai C, Shibata S, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998;95:8227-32.
19. Kishore J, Misra R, Gupta D, Ayyagari A. Raised IgM antibodies to parvovirus B19 in juvenile rheumatoid arthritis. Indian J Med Res 1998;107:15-8.
20. Mimori A, Misaki Y, Hachiya T, Ito K, Kano S. Prevalence of antihuman parvovirus B19 antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis. Rheumatol Int 1994;14:87-90.
21. Oguz F, Akdeniz C, Unuvar E, et al. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. Paediatr Child Health 2002;38:358-62.
22. Lehmann H, Knoll A, Kuster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum 2003;48:1631-8.
23. Brewer EJ Jr, Bass JC, Baum J, et al. Current proposed revision of JRA criteria. Arthritis Rheum 1977;20 Suppl:195-9.
24. Wood PHN. Nomenclature and classification of arthritis in children. In: Munthie E, editor. The care of rheumatic children. Basel: EULAR Publishers; 1978:47-50.
25. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis. J Rheumatol 1998;25:1991-3.
26. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-23.
27. Durigon EL, Erdman DD, Gary GW, et al. Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods 1993;44:155-65.
28. Hokynar K, Brunstein J, Soderlund-Venermo M, et al. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol 2000;81:1017-25.
29. Saal JG, Steidle M, Einsele H, Muller CA, Fritz P, Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 1992;12:147-51.
30. Soderlund M, von Essen R, Haapasaari J, et al. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997;349:1063-5.
31. Kerr JR, Curran MD, Moore JE, Murphy PG. Parvovirus B19 infection: persistence and genetic variation. Scand J Infect Dis 1995;27:551-7.
32. Foto F, Saag KG, Scharosch LL, et al. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J Infect Dis 1993;167:744-8.
33. Kerr JR, Coyle PV, Deleys RJ, et al. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection. J Med Virol 1996;48:68-75.
34. Kurtzman G, Frickhofen N, Kimball J, et al. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989;321:519-23.
35. Kurtzman GJ, Ozawa K, Cohen BJ, et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. New Engl J Med 1987;317:287-94.
36. Manaresi E, Zuffi E, Gallinella G, et al. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins. J Med Virol 2001;64:67-73.